Fatima Kranc, DPhil, is an Investment Manager at Cambridge Enterprise Ventures, focusing on the creation of life sciences spin-outs and start-ups that leverage research from the University of Cambridge. With extensive experience in investment and project management, Fatima holds board positions as Investment Director for Colorifix Limited, Semarion, and Abselion, contributing to innovative developments in sustainable textile production, drug discovery, and biologics quantification. Previous roles include Commercialisation Manager at Babraham Institute Enterprise Ltd, Cancer Research Manager at Cancer Research UK, and Project Development Manager at Cancer Research Technology, showcasing a strong background in translational research and technology transfer. Fatima's academic credentials include a DPhil in Clinical Medicine from the University of Oxford and a Biology degree from the Universidade do Porto.